Sleep apnea is linked to heart failure, but does treatment improve outcome?

Cleveland Clinic Journal of Medicine

Volumn 72, Issue 10, 2005, Pages 929-936

  Wexler, Laura ^a   Javaheri, Shahrokh ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b Sleepcare Diagnostics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN; THEOPHYLLINE;

AROUSAL; ARRHYTHMOGENESIS; ARTERIAL GAS; BREATHING DISORDER; CARDIOVASCULAR SYSTEM; CHEYNE STOKES BREATHING; CLINICAL TRIAL; DISEASE COURSE; DRUG BLOOD LEVEL; HEART ARRHYTHMIA; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; HYPERCAPNIA; HYPOCAPNIA; HYPOXEMIA; OBESITY; OXYGEN THERAPY; POSITIVE END EXPIRATORY PRESSURE; RANDOMIZATION; RESPIRATORY DRIVE; REVIEW; SIDE EFFECT; SLEEP APNEA SYNDROME; SLEEP STAGE; SNORING; THORAX PRESSURE; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT OBSTRUCTION; WEIGHT REDUCTION;

EID: 27744520726     PISSN: 08911150     EISSN: 08911150     Source Type: Journal    
DOI: 10.3949/ccjm.72.10.929     Document Type: Review

References (39)

1. Javaheri S. Sleep-related breathing disorders in heart failure. In: Mann DL, editor. Heart Failure. A Companion to Braunwald's Heart Disease. Philadelphia: WB Saunders, 2004:471-487.
2. Javaheri S. Heart failure. In: Kryger MH, Roth T, Dement W, editors. Principles and Practice of Sleep Medicine, 4th ed. Philadelphia: WB Saunders, 2005:1208-1217.
3. Somers VK, Dyken ME, Mark AL, Abboud FM. Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med 1993; 328:303-307.
4. Javaheri S. Prevalence and prognostic significance of sleep apnea in heart failure. In: Bradley TD, Floras JS, editors. Sleep Apnea. Implications in Cardiovascular and Cerebrovascular Disease. New York: Marcel Dekker, Inc., 2000:415-433.
5. Javaheri S, Parker TJ, Liming JD, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. Circulation 1998; 97:2154-2159.
6. Javaheri S, Parker TJ, Wexler L, et al. Occult sleep-disordered breathing in stable congestive heart failure [erratum in Ann Intern Med 1995; 123:77]. Ann Intern Med 1995; 122:487-492.
7. Hanly PJ, Millar TW, Steljes DG, et al. Respiration and abnormal sleep in patients with congestive heart failure. Chest 1989; 96:480-488.
8. Sin DD, Fitzgerald F, Parker JD, et al. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999; 160:1101-1106.
9. Solin P, Bergin P, Richardson M, et al. Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation 1999; 99:1574-1579.
10. Tremel F, Pepin J-L, Veale D, et al. High prevalence and persistence of sleep apnoea in patients referred for acute left ventricular failure and medically treated over 2 months. Eur Heart J 1999; 20:1201-1209.
11. Lofaso F, Verschueren P, Rande JLD, et al. Prevalence of sleep-disordered breathing in patients on a heart transplant waiting list. Chest 1994; 106:1689-1694.
12. Lanfranchi PA, Braghiroli A, Bosimini E, et al. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation 1999; 99:1435-1440.
13. Chan J, Sanderson J, Chan W, et al. Prevalence of sleep-disordered breathing in diastolic heart failure. Chest 1997; 111:1488-1493.
14. Yasuma F, Nomura H, Hayashi H, et al. Breathing abnormalities during sleep in patients with chronic heart failure. Jap Circ J 1989; 53:1506-1510.
15. Fries R, Bauer D, Heisel A, et al. Clinical significance of sleep-related breathing disorders in patients with implantable cardiciverter defibrillators. Pace 1999; 22:223-227.
16. Staniforth AD, Kinnear WJM, Starling R, et al. Nocturnal desaturation in patients with stable heart failure. Heart 1998; 79:394-399.
17. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea. Am J Respir Crit Care Med 2002; 165:1217-1239.
18. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999; 241:1097-1105.
19. Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med 2002; 347:305-313.
20. Javaheri S. Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure. Circulation 2000; 101:392-397.
21. Mansfield DR, Gollogly C, Kaye DM. Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 2004; 169:361-366.
22. Kaneko Y, Floras JS, Usui K, et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003; 248:1233-1241.
23. Lavie L. Obstructive sleep apnoea syndrome - an oxidative stress disorders. Sleep Med Review 2003; 7:35-51.
24. Javaheri S. Treatment of central sleep apnea in heart failure. Sleep 2000; 23:S224-S227.
25. Javaheri S. Sleep-related breathing disorders in heart failure: diagnosis and treatment. Sleep Med Alert, National Sleep Foundation, 2002; 61:1-5.
26. Javaheri S. Heart failure and sleep apnea: emphasis on practical therapeutic options. Clin Chest Med 2003; 24:207-222.
27. Hanly PF, Millar TW, Steljes DG, et al. The effect of oxygen on respiration and sleep in patients with congestive heart failure. Ann Intern Med 1989; 111:777-782.
28. 2 on sleep-related disordered breathing in ambulatory patients with stable heart failure. Sleep 1999; 22:1101-1106.
29. Javaheri S. Pembrey's dream: the time has come for a long-term trial of nocturnal supplemental nasal oxygen to treat central sleep apnea in congestive heart failure. Chest 2003; 123:322-325.
30. Andreas S, Bingeli C, Mohacsi P, Luscher TF, Noll G. Nasal oxygen and muscle sympathetic nerve activity in heart failure. Chest 2002; 123:366-371.
31. Staniforth AD, Kinneart WJM, Hetmanski DJ, et al. Effect of oxygen on sleep quality, cognitive function and sympathetic activity in patients with chronic heart failure and Cheyne-Stokes respiration. Eur Heart J 1998; 19:922-928.
32. Andreas S, Clemens C, Sandholzer H, et al. Improvement of exercise capacity with treatment of Cheyne-Stokes respiration in patients with congestive heart failure. J Am Coll Cardiol 1996; 27:1486-1490.
33. Myers J, Gullestad L, Vagelos R, Do D, Bellin D, Ross M. Clinical, hemodynamic, and cardiopulmonary exercise test determinants of survival in patients referred for evaluation of heart failure. Ann Intern Med 1998; 129:286-293.
34. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002; 346:793-801.
35. Naughton MT, Bernard DC, Liu PP, et al. Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 1995; 152:473-479.
36. Sin DD, Logan AG, Fitzgerald FS, et al. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 2000; 102:61-66.
37. Dowdell WT, Javaheri S, McGinnis W. Cheyne-Stokes respiration presenting as sleep apnea syndrome. Clinical and polysomnographic features. Am Rev Respir Dis 1990; 141:871-879.
38. Javaheri S, Parker TJ, Wexler L, et al. Effect of theophylline on sleep-disordered breathing in heart failure. N Engl J Med 1996; 335:562-567.
39. Javaheri S Abraham W, Brown C, et al. Prevalence of obstructive sleep apnea and periodic limb movement in 45 subjects with heart transplantation. Eur Heart J 2004; 25:260-266.